<noscript id="2mmmm"><acronym id="2mmmm"></acronym></noscript>
  • <tt id="2mmmm"></tt>
  • <tt id="2mmmm"><rt id="2mmmm"></rt></tt>
  • <table id="2mmmm"></table>
  • <tt id="2mmmm"><rt id="2mmmm"></rt></tt>
    <tt id="2mmmm"><table id="2mmmm"></table></tt>
    中文
    中文
    為了病患而驅動(dòng)的創(chuàng )新
    Patient-first cell therapy innovation

    科學(xué)論文
    SCIENTIFIC PUBLICATION
    • 03.232022
      2018
      Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer. Nat Commun. 9(1):5361. (*: Corresponding authors, PMCID: PMC6299138)Jia Q., Wu W., Wang Y., Alexander P.B., Sun C., Gong Z., Cheng J., Sun H., Guan Y.,
    • 03.232022
      Dr. Qi-Jing Li’s Publication
      Dr. Li has published more than 100 papers on Cell, Cancer Cell, Nature, Nature Immunology, Immunity, EMBO, and Nature Communication, etc. His publications have been cited for more than 9000 times. Below are some selected papers with significant impacts in the scientific field.
    • 03.232022
      Dr. Pin Wang’s Publication
      Dr. Wang has published more than 80 papers on Nature Biotechnology, Cell Stem Cell, PNAS, Nature Communication, ACS Nano, and Molecular Therapy, etc. He has also filed more than 10 patents as lead inventor or co-inventor. Below are some selected papers and patents with significant impacts in the scientific field.
    12
    查看更多

    Copyright ? 2019 天科雅生物醫藥科技有限公司

    粵公網(wǎng)安備 44011502000528號

     粵ICP備20056630號 Powered by vancheer
    關(guān)于天科雅
    研究與發(fā)展
    產(chǎn)品及臨床
    新聞與媒體
    招賢納士

    Copyright ? 2019 天科雅生物醫藥科技有限公司

    粵公網(wǎng)安備 44011502000528號

     粵ICP備20056630號 Powered by vancheer
    精品无码国产自产在线观看水浒传_西西人体444WwW高清大胆_国产探花在线精品一区二区_成人试看120秒体验区